These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30789966)

  • 1. Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve.
    Mahmoud SS; ElAbrak ES; Aly MA; Ali EM
    PLoS One; 2019; 14(2):e0212588. PubMed ID: 30789966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V; Jain NK
    Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising complexes of acetazolamide for topical ocular administration.
    Granero GE; Longhi MR
    Expert Opin Drug Deliv; 2010 Aug; 7(8):943-53. PubMed ID: 20565335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
    Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
    J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery.
    Abbasoğlu E; Tekeli O; Celikdoğan A; Gürsel E
    Eur J Ophthalmol; 2000; 10(1):27-31. PubMed ID: 10744202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].
    Herkel U; Pfeiffer N
    Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation.
    Pisal PB; Joshi MA; Padamwar MN; Patil SS; Pokharkar VB
    Int J Pharm; 2014 Jan; 461(1-2):82-8. PubMed ID: 24291077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment of glaucoma: established and emerging pharmacology.
    Dikopf MS; Vajaranant TS; Edward DP
    Expert Opin Pharmacother; 2017 Jun; 18(9):885-898. PubMed ID: 28480761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical carbonic anhydrase inhibitors for glaucoma].
    Geyer O; Michaeli-Cohen A
    Harefuah; 1996 May; 130(10):705-7. PubMed ID: 8794665
    [No Abstract]   [Full Text] [Related]  

  • 16. An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration.
    Palma SD; Tartara LI; Quinteros D; Allemandi DA; Longhi MR; Granero GE
    J Control Release; 2009 Aug; 138(1):24-31. PubMed ID: 19426769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.
    Maestrelli F; Mura P; Casini A; Mincione F; Scozzafava A; Supuran CT
    J Pharm Sci; 2002 Oct; 91(10):2211-9. PubMed ID: 12226848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
    Meredith SP; Swift L; Eke T; Broadway DC
    J Glaucoma; 2007 Sep; 16(6):556-61. PubMed ID: 17873718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
    Morrison JC; Nylander KB; Lauer AK; Cepurna WO; Johnson E
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):526-31. PubMed ID: 9501862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.